Cognitive Impairment in Huntington Disease
Cognitive Impairment in Huntington Disease is organized by CME Institute of Physicians Postgraduate Press, Inc. (PPP).
Activity opens: 04/21/2023
Activity expires: 04/30/2024
Program Description:
Join Susan Perlman, MD and Christopher Ross, MD, PhD for an in-depth examination of cognitive impairment in Huntington disease. Through this presentation, participants can gain a better appreciation for the non-motor deficits that detract from patient-related quality of life in Huntington disease, describe the neuropathological changes driving disease development, and differentiate between early-stage and late-stage cognitive deficits. In the second half of the presentation, viewers can review key developments in the treatment landscape for non-motor aspects of Huntington disease and evaluate data quantifying the impact of multidisciplinary management approaches. Although Huntington disease lacks a cure and disease-modifying interventions, supportive care strategies can delay the onset of disabilities and alleviate some of the emotional burden associated with non-motor symptoms.
Learning Objectives:
• After completing this educational activity, you should be able to:
• Review the multisystem nature of Huntington disease
• Explore the clinical phenomenology of mild cognitive impairment in Huntington disease, including its impact on executive functioning
• Identify the possible role of NMDA receptors in the pathogenesis and treatment of Huntington disease
• Examine the current and emerging treatment landscape for nonmotor aspects of Huntington disease
• Examine the impact of multidisciplinary management on HD